绥美凯上市后的价格

Suimeikai (dolute abalamib tablets, Inbec) was officially launched in mainland China. This is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China. Suimeike (dolutegravir tablets, Inbec) is a compound preparation. Each tablet contains dolutegravir sodium (calculated as dolutegravir) 50 mg, abacavir sulfate (calculated as abacavir) 600 mg and lamivudine 300 mg. It is suitable for the treatment of adults and adolescents over 12 years old (with a weight of at least 40kg) infected with human immunodeficiency virus (HIV). On January 20, 2018, GlaxoSmithKline China (GSK China) announced that its single-tablet compound preparation Suimeike (dolute abalamib tablets, Inbec) was officially launched in mainland China.

Suimeikai (Domitabalamid Tablets, Inbec) is currently priced at 2,880$/month in the Chinese market. If patients cannot afford the domestic price of Suimeikan (Domitabalamid Tablets, Inbec), they can choose to buy the original drug Suimeike (Domitabalamid Tablets, Inbec) available in India. The price is relatively cheaper. India Emcure The company's Suimeikan (Abalamid Tablets, Inbec) comes in a box of 30 tablets, priced at approximately RMB 1,000. It is the most cost-effective version of Suimeikan (Abalamid Tablets, Inbec) in the world. 

There are generally two most reliable ways to buy genuine Indian Suimeike (Dolutea Paramid Tablets, Inbec): First, if you are able, the patient himself goes to a well-known hospital in India and goes to the corresponding pharmacy to get the medicine according to the prescription issued by the attending doctor. This can ensure formal channels for obtaining medicines from the source. The second way is to find a professional overseas medical service organization in China (such as Medical Travel). Medical Travel has cooperation with foreign pharmaceutical companies and can help you buy genuine Indian Suimeike (Dolute Abalami Tablets, Inbec).